Strong laboratory leaders - a key asset for global disease control
Laboratories play an essential role in the detection, diagnosis, prevention and control of diseases. To strengthen this role, ECDC and five partner organisations have developed the Global Laboratory Leadership Programme (GLLP) to support and sustain national laboratory systems under a One Health approach.
Europe is steadily building more robust laboratory defences against epidemics and antimicrobial resistance threats
ECDC’s report EU Laboratory Capability (EULabCap) published on the 30th of April, based on the results of the 2016 survey, concludes that the EU/EEA can rely in a public health microbiology system with strong overall capabilities and substantial capacity to fulfil EU surveillance and response.
Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
ECDC ENLabCap consultation meeting with EU enlargement countries
Overall aim of this regional ENLabCap consultation workshop was to discuss the adjustments proposed to the current EULabCap tool and agree on those needed to adapt it for the EU enlargement countries.
European laboratories move forward towards stronger epidemic readiness for infectious disease threats.
The latest EULabCap data on assessing the public health laboratory capacities among 30 EU and EEA countries in 2016 reveal continuous improvement in reducing inequalities, with ten more countries reaching fair to high capability levels over the 4 years of monitoring.